Crossflow onboards new pharma and retail clients and global funders

3 February 2020

In partnership with its corporate clients, Crossflow has extended $2.4bn in working capital relief to thousands of global suppliers with its technology-powered platform.

Crossflow has onboarded new global pharma and retail leaders, working with them to plan and roll out working capital programmes to increase their working capital by extending payment terms and enabling their suppliers to get paid in two days rather than 30, boosting their working capital.

In tandem with this, Crossflow has also onboarded new funders to its marketplace, including global financial institutions and alternative investment funds. Crossflow’s current funding capacity is $1.9bn.